Journal of Mass Spectrometry and Advances in the Clinical Lab (Nov 2022)
Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]
- Karl Hansson,
- Rahil Dahlén,
- Oskar Hansson,
- Elin Pernevik,
- Ross Paterson,
- Jonathan M. Schott,
- Nadia Magdalinou,
- Henrik Zetterberg,
- Kaj Blennow,
- Johan Gobom
Affiliations
- Karl Hansson
- Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- Rahil Dahlén
- Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- Oskar Hansson
- Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden; Memory Clinic, Skåne University Hospital, Malmö, Sweden
- Elin Pernevik
- Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- Ross Paterson
- Dementia Research Centre, UCL Institute of Neurology, London, UK
- Jonathan M. Schott
- Dementia Research Centre, UCL Institute of Neurology, London, UK
- Nadia Magdalinou
- Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, Queen Square, London, UK
- Henrik Zetterberg
- Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- Kaj Blennow
- Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- Johan Gobom
- Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Corresponding author at: Institute of Neuroscience and Physiology, Department of Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 80 Mölndal, Sweden.
- Journal volume & issue
-
Vol. 26
p. 35